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Abstract
Background: The development of microarray technology has greatly enhanced our ability to
evaluate gene expression. In theory, the expression of all genes in a given organism can be
monitored simultaneously. Sequencing of the chicken genome has provided the crucial information
for the design of a comprehensive chicken transcriptome microarray. A long oligonucleotide
microarray has been manually curated and designed by our group and manufactured using Agilent
inkjet technology. This provides a flexible and powerful platform with high sensitivity and specificity
for gene expression studies.
Results: A chicken 60-mer oligonucleotide microarray consisting of 42,034 features including the
entire Marek's disease virus, two avian influenza virus (H5N2 and H5N3), and 150 chicken
microRNAs has been designed and tested. In an important validation study, total RNA isolated
from four major chicken tissues: cecal tonsil (C), ileum (I), liver (L), and spleen (S) were used for
comparative hybridizations. More than 95% of spots had high signal noise ratio (SNR > 10). There
were 2886, 2660, 358, 3208, 3355, and 3710 genes differentially expressed between liver and
spleen, spleen and cecal tonsil, cecal tonsil and ileum, liver and cecal tonsil, liver and ileum, spleen
and ileum (P < 10-7), respectively. There were a number of tissue-selective genes for cecal tonsil,
ileum, liver, and spleen identified (95, 71, 535, and 108, respectively; P < 10-7). Another highlight of
these data revealed that the antimicrobial peptides GAL1, GAL2, GAL6 and GAL7 were highly
expressed in the spleen compared to other tissues tested.
Conclusion: A chicken 60-mer oligonucleotide 44K microarray was designed and validated in a
comprehensive survey of gene expression in diverse tissues. The results of these tissue expression
analyses have demonstrated that this microarray has high specificity and sensitivity, and will be a
useful tool for chicken functional genomics. Novel data on the expression of putative tissue specific
genes and antimicrobial peptides is highlighted as part of this comprehensive microarray validation
study. The information for accessing and ordering this 44K chicken array can be found at http://
people.tamu.edu/~hjzhou/TAMUAgilent44KArray/
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The chicken, being the first farm animal with a completely
sequenced genome, has become an important animal
model in the fields of evolution, development, immunol-
ogy, oncology, cell biology, virology, and genetics [1,2].
Candidate genes, QTL, and molecular markers have been
widely utilized to reveal the genetic basis of economically
important traits in chickens [3-5]. There are also many
new genetic and bioinformatics resources available that
are based upon chicken genome information, including
genetic and physical maps [6], EST databases [7], and SNP
maps [1,8]. Global gene expression profiling will provide
a complementary tool improving our ability to study reg-
ulation of complex and economically important traits in
chickens.
The development of high-throughput microarray has
accelerated the study of gene expression by interrogating
thousands of genes simultaneously [9-11]. Microarray
technologies provide an important tool to infer gene net-
works and to identify highly conserved genetic pathways
in plants and animals. There have been many important
studies contributing to gene expression profiling in agri-
cultural animals including pigs [12,13], rabbits [14], and
cattle [15,16]. Several chicken cDNA or oligonucleotide
probe (oligo) arrays have also been developed and uti-
lized in gene expression studies. These arrays include a
3,011 lymphocyte array [17], a 3,072 intestinal array [18],
an 11K heart specific array [19], a 14,718 macrophage
specific array [20], a 13K cDNA transcriptome array [21],
a 5K immune related array [21,22], a 20K long oligo
chicken genome array [23], and a 33K Affymetrix chicken
genome array [24].
Short and long oligo arrays have several advantages over
cDNA arrays in terms of specificity, sensitivity, and repro-
ducibility [25]. Both microarray technologies can provide
comprehensive and reliable data for global expression
analyses. However, oligos are more uniform in concentra-
tions and annealing temperature, more gene-specific, flex-
ible, and economic. Long oligos can provide increased
signal intensity compared to short ones [26,27]. Long
oligo arrays generated by Agilent Technology may be able
to detect down to single transcript per cell [25]. This 60-
mer 44K chicken whole genome custom array which was
developed by our group and manufactured using the Agi-
lent Technology will provide a comprehensive and power-
ful functional genomics tool for the agricultural
community.
Results
Genes selected on the array
A total of 42,034 probes were designed based on the
whole chicken genome sequence including autosomes,
sex chromosomes, unlocalized chromosomes (i.e.
E22C19W28, E26C13 and E50C23), and mitochondria
(Figure 1), plus 1264 positive control features and 153
negative control features. Chicken chromosomes range
from 0.15 Mb to 188.2 Mb [6]. In order to calculate the
probe density (number of probes per Mb) on each chro-
mosome, the number of probes targeted to each chromo-
some was divided by the length of the chromosome. The
probe density ranged from 28 probes per Mb (Chr. 16) to
445 probes per Mb (Chr. 2), with a mean value of 76. This
array also included probes designed from 150 chicken
microRNA, 43 Marek's disease virus genes, and 20 avian
influenza virus genes (10 H5N2 and 10 H5N3 genes).
Array quality
The signal-to-noise ratio (SNR) for each element was cal-
culated using the difference of the median intensity,
minus the median background, divided by the standard
deviation of the background [28]. The percentage of high
quality spots (SNR > 10) were calculated as the number of
high quality spots divided by the total number of spots on
the array. For all 24 arrays, the average percentage of high
quality spots was determined to be 96.55 ± 4.89%.
To evaluate the array quality, two comparisons were car-
ried out: (1) two biological replicates from the same tissue
labelled with the same dye and (2) the same samples
labelled with Cy5 and Cy3. The correlation coefficients of
signal intensities between the two biological replicates
and between the two different dyes compared among the
same samples (dye swap) were calculated by JMP 5.5 (SAS
Institute, Cary, NC) (Figure 2). The correlation coeffi-
cients between two biological replicates of cecal tonsil
Number of probes in the microarray represented in each chromos meFigur  1
Number of probes in the microarray represented in 
each chromosome. U represents ChrUn_random; M rep-
resents mitochondrial sequence; O represents other chro-
mosome, like chrE22, E64.
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BMC Genomics 2008, 9:60 http://www.biomedcentral.com/1471-2164/9/60labelled with Cy5 or Cy3 were 0.99, 1.00, respectively. The
regression lines between two biological replicates of cecal
tonsil labelled with Cy5 or Cy3 were y = 0.9779x + 0.0057
(R2 = 0.99) and y = 0.9778x (R2 = 0.99), respectively (Fig-
ures 2A, B). Dye swaps were utilized throughout this study
in order to avoid the dye bias. The correlation coefficient
and regression line between cecal tonsils labelled with
Cy5 and Cy3 were 1.00 and y = 0.99x (R2 = 0.98), respec-
tively (Figure 2C).
Gene expression in different tissues
Before normalization, signal intensities of each feature
were filtered against negative controls in the array. The
ratio of signal intensity for each gene and the average sig-
nal intensity of negative control elements were calculated.
An arbitrary ratio of 1.5 was used to determine if a partic-
ular gene was expressed in a given tissue. It was found that
43.83% of all genes on the array were expressed within all
four tissues. Looking at each tissue individually, it was
found that 71.11%, 80.05%, 75.37%, and 80.22% of the
genes on the array were expressed in cecal tonsil, ileum,
liver, and spleen, respectively.
A comparative study was conducted by comparing gene
expression profiles between each of the four selected tis-
sues (cecal tonsil, ileum, liver, and spleen). There were
3710, 3355, 3208, 2886, 2660, and 358 genes signifi-
cantly and differentially expressed between spleen and
ileum, liver and ileum, liver and cecal tonsil, liver and
spleen, spleen and cecal tonsil, and cecal tonsil and ileum
at the cut-off of P < 10-7. The corresponding false discov-
ery rate (FDR) for each comparison was calculated and
shown to be 4.46 × 10-7, 4.14 × 10-7, 4.37 × 10-7, 5.02 ×
10-7, 7.39 × 10-7 and 9.11 × 10-6, respectively. Out of the
150 chicken microRNAs included in this microarray, it
was shown that 15, 36, 31, 24, 15, and 11 microRNAs
were differentially expressed when comparing spleen and
ileum, liver and ileum, liver and cecal tonsil, liver and
spleen, spleen and cecal tonsil, and cecal tonsil and ileum
(P < 0.05).
The correlation of signal intensities between biological replicates and dye swapsFigure 2
The correlation of signal intensities between biological replicates and dye swaps. A. The correlation of signal inten-
sities between two individual cecal tonsil (C) samples labeled with Cy5, Y = 0.98 X+0.0057, R2 = 0.99. B. The correlation of sig-
nal intensities between two individual cecal tonsil (C) samples labeled with Cy3, Y = 0.98 X, R2 = 0.99. C. The correlation of 
signal intensities between the same cecal tonsil (C) sample labeled with Cy3 and Cy5, Y = 0.99 X, R2 = 0.98.
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BMC Genomics 2008, 9:60 http://www.biomedcentral.com/1471-2164/9/60There were three pairs of tissue gene expression compari-
sons performed for each tissue as part of this study. These
comparisons were used to obtain a list of genes that are
specifically expressed in each tissue (Figure 3). In sum-
mary, there were 286, 489, 4102, and 3929 genes signifi-
cantly expressed in cecal tonsil, ileum, liver, and spleen (P
< 10-3), respectively; 167, 201, 1627, and 1141 genes at
cut-off P value of 10-5, and 156, 88, 737, and 378 genes at
P < 10-7.
Fold change is an indication of relative gene expression
differences. It is considered that genes, which are
expressed at a higher level in one tissue compared to all
other tissues, are "tissue-selective" genes [29]. Those genes
which are significantly expressed with at least two-fold
higher expression in one tissue when compared to the
other three tissues are considered to be selectively
expressed in this tissue. The data on the selectively
expressed genes at three different cut-off P values (10-3, 10-
5, and 10-7) as determined in this study are listed in Table
1. There were 120, 153, 857, and 541 genes selectively
expressed in the cecal tonsil, ileum, liver and spleen at P <
10-3, respectively. There were 103, 115, 736, and 291
selective genes respectively at a cut-off P value of 10-5 and
there were 95, 71, 535, and 108 selective genes at a cut-off
P value of 10-7. The selectively expressed genes expressed
at P < 10-7 are listed in the additional data files 1, 2, 3, 4.
Gene ontology
Functional category enrichment evaluation based on the
gene ontology (GO) was performed on the differentially
expressed genes for each tissue comparison (Figure 4, 5,
6). There are three components to a GO annotation: cel-
lular component (CC), molecular function (MF), and bio-
logical process (BP). Biological Processes may arguably be
the more relevant aspect of GO in relation to this study,
therefore, only functional clusters belonging to this com-
ponent have been presented. Comparatively induced
genes from liver when individually compared to the other
three tissues showed GO BP enrichments associated with
cellular biosynthesis, cellular lipid metabolism, coagula-
tion, hemostasis, metabolism, nitrogen compound
metabolism, and physical process (Figure 4A). GO BP
enrichment analysis of repressed liver genes for each of
the three comparisons identified the categories of actin
cytoskeleton organization and biogenesis, cell differentia-
tion, cell organization and biogenesis and development.
There were many significantly enriched functional catego-
ries associated with comparatively repressed genes when
only considering the comparisons between liver and
spleen, and liver and cecal tonsil. These were cellular
physiological processes, primary metabolism, macromol-
ecule biosynthesis, macromolecule metabolism, develop-
ment, protein biosynthesis, protein metabolism, and
regulation of cellular process (Figure 4B). GO BP enrich-
ments of induced genes in the spleen revealed enriched
categories that included biopolymer metabolism, nucleo-
base, nucleoside, nucleotide and nucleic acid metabolism,
physiological process, and primary metabolism (Figures
4B, 5). Induced genes in comparisons of cecal tonsil with
liver and ileum showed functional enrichment primarily
categorized as cell death (Figures 4B, 5). Comparisons of
repressed genes in cecal tonsils with both spleen and liver
showed enrichments associated with physiological proc-
ess and response to stress (Figures 4A, 5). In the functional
comparisons of induced genes from ileum with both
spleen and liver, there were enrichments associated with
development (Figures 4B, 6); however, the repressed
genes in ileum when compared to spleen and liver
showed functional enrichment of cellular biosynthesis,
physiological process, and protein biosynthesis (Figures
4A, 5).
Quantitative real time PCR
To validate the microarray results, quantitative real time
PCR (qRT-PCR) assays were performed on the same RNA
samples used for the microarrays. A total of 23 genes were
selected for these verifications. These genes included
induced and repressed genes that were significantly and
Table 1: The number of tissue selective genes at certain cut-off P 
values
Cut-off Cecal tonsil Ileum Liver Spleen
10-3 120 153 857 541
10-5 103 115 736 291
10-7 95 71 535 108
Venn diagram showing the number of specifically expressed genes in each tissueFigure 3
Venn diagram showing the number of specifically 
expressed genes in each tissue. A. Gene number at cut-
off P values of 10-3. B. Gene number at cut-off P values of 10-
5. C. Gene number at cut-off P values of 10-7.
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Significantly enriched Gene Ontology (GO) terms for Biological Process classification of the differentially expressed genesFigure 4
Significantly enriched Gene Ontology (GO) terms for Biological Process classification of the differentially 
expressed genes. A. Up regulated genes between liver and cecal tonsil, liver and ileum, and liver and spleen. B. Down regu-
lated genes between liver and cecal tonsil, liver and ileum, and liver and spleen. nucleobase, nucleoside, nucleotide and nucleic 
acid ...: nucleobase, nucleoside, nucleotide and nucleic acid metabolism. Percentage shown in Y-axis was calculated as genes in 
each GO term divided by all up regulated or down regulated genes in each comparison.
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BMC Genomics 2008, 9:60 http://www.biomedcentral.com/1471-2164/9/60non-significantly expressed (Table 2). The relative signal
intensities of those genes selected for qRT-PCR ranged
from low to high (10 to 65535). Glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) was used as the normali-
zation standard.
The coefficient of variation between the replicate qRT-PCR
reactions was calculated and ranged from 0.1%-2%. For
the genes with P < 5 × 10-4 in microarray results, 95.5% of
the genes tested by qRT-PCR were also differentially
expressed (P < 0.05); for genes 5 × 10-4<P < 0.05 in the
microarray only 16.7% were significantly and differen-
tially expressed (P < 0.05) using qRT-PCR; none of the
genes with P > 0.05 were shown to be differentially
expressed using qRT-PCR. In terms of regulation direction
for the genes in each qRT-PCR comparison, the microar-
ray results were always consistent with qRT-PCR for genes
with P < 0.0001, but only 75% when considering genes
with 0.0001 <P < 0.05, and genes with P > 0.05, we found
78.57% of genes were consistently expressed between
microarray and qRT-PCR (Tables 3 and 4). The fold-
changes (log2 ratio) of each gene for six comparisons are
presented in Tables 3 and 4. Most of fold-changes in qRT-
PCR were higher than those seen in microarray compari-
sons.
Utilization of the array
MIAME information about this chicken transcriptome
microarray has been deposited in NCBI's Gene Expression
Omnibus (GEO) [30]. The accession numbers are: Plat-
form, GPL4993; Series, GSE7452; Samples,
GSM180391–GSM180406, GSM180426, GSM180428,
GSM180430, GSM180433, GSM180434, GSM180436,
GSM180438, GSM180441.
Discussion
Microarray performance
Three different types of microarrays have been widely uti-
lized in genome research including cDNA (long strands of
amplified cDNA sequences), short oligonucleotide
(25–30 nt), and long oligonucleotide (50–80 nt). Several
studies have compared the performance of different plat-
forms [10,13,31-34]. Annotation and identity of the com-
mercial oligonucleotides are reliable and the probe
Significantly enriched Gene Ontology (GO) terms for Biological Process classification of the differentially up regulated genes between cecal tonsil and ileum, spleen and cecal tonsil, spleen and ileumFigur  5
Significantly enriched Gene Ontology (GO) terms for Biological Process classification of the differentially up 
regulated genes between cecal tonsil and ileum, spleen and cecal tonsil, spleen and ileum. Percentage shown in Y-
axis was calculated as genes in each GO term divided by all up regulated or down regulated genes in each comparison.
0
10
20
30
40
50
60
70
80
90
bi
op
ol
ym
er
 m
et
ab
ol
is
m
bi
os
yn
th
es
is
ce
ll 
cy
cl
e
ce
ll 
de
at
h
ce
llu
la
r b
io
sy
nt
he
si
s
ce
llu
la
r m
ac
ro
m
ol
ec
ul
e 
m
et
ab
ol
is
m
ce
llu
la
r p
hy
si
ol
og
ic
al
 p
ro
ce
ss
ce
llu
la
r p
ro
te
in
 m
et
ab
ol
is
m
D
N
A
 m
et
ab
ol
is
m
D
N
A
 re
pa
ir
D
N
A
 re
pl
ic
at
io
n
D
N
A
-d
ep
en
de
nt
 D
N
A
 re
pl
ic
at
io
n
M
 p
ha
se
m
ac
ro
m
ol
ec
ul
e 
bi
os
yn
th
es
is
m
ac
ro
m
ol
ec
ul
e 
m
et
ab
ol
is
m
nu
cl
eo
ba
se
, n
uc
le
os
id
e,
 n
uc
le
ot
id
e 
an
d 
nu
cl
ei
c 
ac
id
 m
et
ab
ol
is
m
ph
ys
io
lo
gi
ca
l p
ro
ce
ss
pr
im
ar
y 
m
et
ab
ol
is
m
pr
ot
ei
n 
bi
os
yn
th
es
is
pr
ot
ei
n 
m
et
ab
ol
is
m
re
gu
la
tio
n 
of
 b
io
lo
gi
ca
l p
ro
ce
ss
re
gu
la
tio
n 
of
 c
el
lu
la
r p
ro
ce
ss
re
gu
la
tio
n 
of
 p
hy
si
ol
og
ic
al
 p
ro
ce
ss
re
sp
on
se
 to
 D
N
A
 d
am
ag
e 
st
im
ul
us
re
sp
on
se
 to
 e
nd
og
en
ou
s 
st
im
ul
us
re
sp
on
se
 to
 o
th
er
 o
rg
an
is
m
re
sp
on
se
 to
 p
es
t, 
pa
th
og
en
 o
r p
ar
as
ite
re
sp
on
se
 to
 s
tim
ul
us
re
sp
on
se
 to
 s
tre
ss
R
N
A
 m
et
ab
ol
is
m
%
 o
f G
en
es
S vs I induced
S vs C induced
C vs I induced
 Page 6 of 14
(page number not for citation purposes)
BMC Genomics 2008, 9:60 http://www.biomedcentral.com/1471-2164/9/60performance is excellent [32]. Commercial microarrays
can provide higher precision than homemade microarrays
[33]. This custom long-oligo array was generated by the
Agilent SurePrint ink-jet technology, which also provides
a flexible platform for revising and updating oligonucle-
otide probes in the array without additional cost [25,35].
Only small amount of RNA is needed for labelling (50 ng
to 5 μg of total RNA or 10–100 ng of poly (A)+ RNA) [35],
compared to at least 20–30 μg total RNA using cDNA
array. This is especially important for those applications
that generate limited amounts of RNA, such as laser-cap-
ture.
Chicken, as a major food animal, plays a key role in nutri-
tion and food safety for human health, and is a model
organism in developmental biology and for disease
research including virology, oncology, and immunology
[36]. There were several chicken whole genome microar-
rays as noted in the introduction. The currently described
44K long oligonucleotide (60-mer) microarray has shown
overall high array quality and specificity compared to
cDNA and 25-mer oligo arrays [37]. In addition, the 4 ×
44K platform in the array design has the feature of four
independent arrays in one slide, which is more cost effec-
tive and can also reduce variations among the arrays
within a slide. The design of this array was based on
expressed sequences selected by walking over the chicken
genome sequences in the UCSC genome browser. This
manual approach allowed us to maximize genome cover-
age and minimize gene redundancy.
High background levels in an array platform can obscure
the signal from low-expressed genes and impede accurate
quantification. The magnitude of SNR can affect the sen-
sitivity of the microarray, and a higher SNR indicates high
sensitivity and low background. In general, SNR > 3 was
used as the lower-bound threshold for spot detection [21]
in the current microarray studies and a SNR > 10 was the
indication of high quality spots [28]. More than 95% of
the spots with SNR > 10 in the array compared to 86.3 to
88.9% with SNR > 3 for the chicken cDNA array [21] have
demonstrated the high sensitivity of the current array. The
average SNR of the current microarray was 921.93, which
was much higher than the SNR of most cDNA array plat-
forms (35.1 to 38.3). This will promote sufficient signal
generation for the detection of even low copy genes.
Quantitative real time PCR has become the gold standard
for the gene expression and generally used to validate the
microarray results [38]. At the criterion of P < 5 × 10-4 in
the microarray analysis, false positives could be effectively
controlled (95.5% consistency between microarray and
qRT-PCR). For those 4.5% inconsistent ones, large varia-
tions were observed between four biological replicates
within each tissue using the more sensitive qRT-PCR
method, which caused higher P values. On the other
hand, the results from qRT-PCR demonstrated that type II
errors (false negatives) can be controlled, given certain
cut-off P value from microarray analysis (100% true false,
given P > 0.05). These results indicated that microarray
analyses from the current array were statistically reliable
and accurate.
Genes on the microarray
This whole genome 44 K microarray consists of probes
designed from all potential genes and was designed based
on the February 2004 chicken (Gallus gallus) v1.0 draft
assembly. The current array design includes all of the
available (150) chicken microRNAs from miRBase 8.1
[39,40], all known Marek's disease virus and two avian
influenza virus (H5N2 and H5N3) transcripts. This array
platform will provide a unique opportunity to study host-
pathogen interaction using the same array simultane-
ously. This is important as we currently face potential
emergence of an avian influenza virus epidemic. A second
version of this array based on May 2006 chicken (Gallus
gallus) v2.1 draft assembly has been updated and is now
available.
A strict statistical criterion has been applied in the current
analysis. Several thousand genes were differentially
Significantly enriched Gene Ontology (GO) terms for Biolog-ical Process classification of the differentially down regulated genes betwe  cecal sil and ileum, spleen and cecal tonsil,spleen d il umFigu e 6
Significantly enriched Gene Ontology (GO) terms for 
Biological Process classification of the differentially 
down regulated genes between cecal tonsil and 
ileum, spleen and cecal tonsil, spleen and ileum. Gen-
eration of precursor metab...: generation of precursor 
metabolites and energy. Percentage shown in Y-axis was cal-
culated as genes in each GO term divided by all up regulated 
or down regulated genes in each comparison.
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BMC Genomics 2008, 9:60 http://www.biomedcentral.com/1471-2164/9/60expressed between every two tissue comparison even at P
< 10-7. Because there were more than 40 thousand genes
analyzed in this microarray experiment; therefore, it is
important to control the proportion of false positives
[41]. False discovery rates (FDR) based on P values is the
expected proportion of true null hypotheses rejected in
relation to the total number of null hypotheses rejected
[42]. FDR is a more convenient and natural scale than the
P-value scale, and it can provide the probability of a gene
value to be false positive [43]. In this study, the FDRs were
less than 5% for a P value of 10-7, which demonstrated the
reliable results of the current microarray experiment. Sim-
ilar FDR were observed in gene expression profiling
between different tissues using a long oligo swine array
[12].
Gene expression profiles of different normal tissues pro-
vide information about the biological function of the tis-
sue and are expected to be conserved during evolution.
Liver, spleen, and ileum have been widely utilized in gene
expression profiling studies in human [29,44-46] and
swine [12,47]. There were some common gene ontology
terms enriched with tissue comparison between spleen
and ileum in both human [44] and chickens such as pro-
tein biosynthesis, energy pathways, and immune
response. But there were some distinct enrich terms
between human and chickens including cytochrome C
oxidase activity in human, and cell death, development,
M phase, macromolecule metabolism, and physiological
process in chicken. For the comparison of liver and
spleen, energy pathways, main pathways of carbohydrate
metabolism, and fatty acid oxidation were enriched in
human [44], while generation of precursor metabolites
and energy, cellular carbohydrate metabolism, cellular
lipid metabolism, tricarboxylic acid cycle organic acid
metabolism were enriched in chickens (Figures 4A, B).
Cecal tonsil and ileum are two proximal tissues in the
digestive tract. Both of these are critical components of
gut-associated immune system. They might share many
common functions, which means, there might be fewer
genes differentially expressed between them. The lowest
Table 2: The gene symbol, accession number, and primers of genes used for quantitative RT-PCR
Gene symbol Accession No.(GenBank) Forward primer (5'-3') Reverse primer (5'-3')
IGJ AB025103 GAAGGGAAGGCAAGATGAAG GGGACGAACTTTGAGGTCAC
TF AB215094 AACAACCTCAGGGACCTCAC GTCCAAGCTAATGGCATCTG
GSTA3 AF133251 CAGAGCCATCCTCAGCTACA CTCTGTTGCCTTCTCTGCAA
LCP2 AF226988 TGAATCACCAACGGAAGAAA ACTGGAGGCTGATGTGATGA
CXCL14 AF285876 GTGCTTAGCCAGTGCAGAAG TCCTCCACACAAAATGGGTA
Lb-FABP AF380998 CTGGCAGGTCTATGCTCAAG CACAGTCTGCCTGGGTGTT
FABP1 AF380999 TTCTCTTGTGTTGGGAGCAC TTCCCATTCTGCACAATTTC
FIGF AF479650 CTCGGTTCCTTTGACAAGTG CTATCCCAGACCCATCCATT
CYP3A37 AJ250337 ATACGGACAGACCTCCAAGC GAATGCCCAGCTTCTTGAAC
MARCO AJ271377 CAGATGCAGAGGAGATGGAA GCAGCAGGTAGATGACAAGG
BCMO1 AJ271386 AAACTTCCAACTTCCGCAAC GTAGGAACTGGGCTCCACTG
TIMD4 AJ719444 GTCAGCCAAAATGTCCCACT GTCCTTCTCTCGTGCTACCC
TNFSF10 AJ720191 TGGCCGTCACCTACATCTAC TCAGCCACTCTGTCTTTGCT
LEAP-2 AY534899 TTCTGAGACTGAAGCGGATG GAGGCCGTTCTAAGGAAGC
TACSTD1 BU137789 CCCTGGAGATGTGGATATAACTG TCTGGTGGTACTTCATCAACG
HRSP12 BX932754 GCTTGTAGACCGGACCATGT GCAGCTTTCAGGATTTCTCC
C1QA BX934534 CATGGAACAGCTTGAGGATG GCCCTGATTCACCTTTGTCT
GAL10 CR388516 GCTCTTCGCTGTTCTCCTCT CCCAGAGATGGTGAAGGTG
VIP U09350 CTGTCAAACGCCACTCTGAT CGAAGTTTGGCTGGATTTAAC
C3 X69470 GACGTCCAGGACCTGAAGAG CCAGGTAGATGATGAGGTTGC
VLDLR X80207 ATGTGAGGAGTCCCAGTTCC CCATCACACTGCCATCTGTT
CD5 Y12011 ACAGGAGGCTGATGAAGAGG TGAGCGTAATCGTTGTCTCC
K60 Y14971 CGATGCCAGTGCATAGAGAC GTCCAGAATTGCCTTGATGA
GAPDH NM_204305 GAGGGTAGTGAAGGCTGCTG CATCAAAGGTGGAGGAATGG
IGJ: Immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides; TF: Transferrin; GSTA3: Glutathione S-Transfer 
A3; LCP2: Lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76 KDA); CXCL14: Chemokine (C-X-C motif) ligand 14; 
Lb-FABP: Liver basic fatty acid binding protein; FABP1: Fatty acid binding protein1, liver; FIGF: 'C-fos induced growth factor (vascular endothelial 
growth factor D); CYP3A37: Cytochrome P 450 A 37; MARCO: Macrophage receptor with collagenous structure; BCMO1: Beta-carotene 15, 15'-
monooxygenase 1; TIMD4: T-cell immunoglobulin and mucin domain containing 4; TNFSF10: Tumor necrosis factor (ligand) superfamily, member 
10; LEAP-2: Liver expressed antimicrobial peptide 2; TACSTD1: Tumor associated calcium signal transducer 1; HRSP12: Heat responsive protein 
12; C1QA: Complement component 1, Q subcomponent, alpha polypeptide; GAL10: Beta-defensin 10; VIP: Vasoactive intestinal peptide; C3: 
Complement component 3; VLDLR: Very low density lipoprotein receptor; CD5: CD5 protein; K60: K60 protein; GAPDH: Glyceraldehyde 3-
phosphate dehydrogenase.Page 8 of 14
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BMC Genomics 2008, 9:60 http://www.biomedcentral.com/1471-2164/9/60number of differentially expressed genes (358) was found
in the comparison of cecal tonsil and ileum. These find-
ings support the expectation that tissues with similar gene
expression might have similar biological functions.
Liver is a major organ with important biological functions
like lipid metabolism. More genes specifically expressed
in liver than spleen and ileum and/or other tissues in
human and swine [12,44,46]. Similar results were
observed in chickens. In human, oxidoreductase activity,
lipid metabolism, complement activation, steroid metab-
olism, alcohol metabolism, cytochrome P450 activity,
urea cycle, coagulation, amino acid metabolism, bile acid
biosynthesis, and carbohydrate metabolism were liver-
selective [29,44,45,48]. In swine, coagulation pathway,
alcohol metabolism, lipid processing, bile metabolism
and xenobiotic metabolism were liver-specific [12]. In the
current study, energy, metabolism, especial fatty acid
metabolism-related genes, fatty acid or lipid binding pro-
tein, fatty acid synthase, cholesterol hydroxylase, lectin,
adenyl nucleotide binding, ATPase, hydrolase, coagula-
tion factor, cytochrome P450, lyase, C3, C4B, C8, phos-
phorylase, and oxidoreductase, were found liver-selective
(see additional file 3).
Spleen is one of the major immune organs. Many
immune-related genes were more highly expressed in
spleen than the other three tissues in chickens. Similar
results have been observed using northern blot hybridiza-
tion [49], moreover, it was reported that immune
response genes were selectively expressed in human
spleen [44] and porcine small intestine [12]. Ileum is one
of the more important tissues involved as part of bacterial
pathogenesis studies in agricultural animals. Genes
related to interaction between organisms and viral life
cycle were specifically expressed in porcine ileum cDNA
libraries [50]. In chickens, class II histocompatibility anti-
gen, B-L beta chain and C7 were found ileum-selective
(see additional file 2). No ileum-selective genes were
available in human from the previous studies. The con-
served gene expression profiles in tissue comparisons
among species have provide a solid basis for comparative
genomics study. The tissue-selective genes could be poten-
tially used as markers for the origin of pathogen, like gut-
related pathogens.
Perhaps one of the most important and interesting find-
ings in the study was in relation to antimicrobial peptides
(AMPs). AMPs are essential for the innate immune
response in plants, flies, mammals, and chickens. There
are two major families of AMPs: defensins and cathelici-
dins. Fourteen β-defensins, known as gallinacins (GAL)
and cathelicidin have been described in chickens [51-53].
In the present study, GAL1, GAL2 and GAL6-7 showed
Table 3: Microarray and qRT-PCR results of 23 selected genes for each pair of comparison
Gene symbol Liver vs. spleen Spleen vs. cecal tonsil Cecal tonsil vs. ileum
Microarray qRT-PCR Microarray qRT-PCR Microarray qRT-PCR
IGJ -4.9 # -7.1 2.3 # 2.3 3.0 # 2.2
VLDLR -3.2 # -3.5 1.6 # 2.1 0.2 0.7
LEAP-2 4.5 # 10.0 -1.0 * -5.5 -2.8# -4.5
Lb-FABP 8.6 # 12.6 -0.8 0.0 -0.3 -1.0
TACSTD1 1.9 # 4.1 -5.7 # -3.5 0.0 -2.9
CYP3A37 3.1 # 14.8 -3.6 # -14.8 -0.1 0.2
C1QA -0.5 * -0.6 2.0 # 2.8 0.2 -0.2
MARCO -0.6 * -3.7 2.7 # 4.7 0.1 1.4
BCMO1 1.8 # 4.8 0.8 * -1.3 -2.1 # -2.6
K60 -0.9 # -2.3 -0.8 # -1.6 2.0 # 3.0
GSTA3 3.1 # 7.0 -3.4 # -3.9 2.3 # 1.0
FIGF -1.0 * -0.6 -2.6 # -1.8 1.0 * 0.9
CD5 -3.2 # -4.2 0.3 0.6 2.6 # 2.2
GAL10 5.0 # 12.7 -0.1 -2.1 0.0 -1.1
TF 4.2 # 7.2 0.9 * 4.4 0.6 0.7
VIP 0.0 -2.2 -3.2 # -3.7 -0.6 -0.6
CXCL14 0.1 -5.8 -2.6 # -6.4 0.3 0.0
HRSP12 3.7 # 6.0 -0.8 * -1.8 0.3 -0.8
C3 2.8 # 3.0 0.2 1.7 0.6 3.0
FABP1 8.6 # 13.5 -0.8 # -6.0 -0.3 -2.7
TNFSF10 1.4 # 1.3 -3.3 # -3.3 0.6 0.2
LCP2 -2.0 # -0.5 1.1 # 1.0 1.1 * -0.1
TIMD4 0.0 -0.1 2.0 # 2.5 1.4 # 1.0Page 9 of 14
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BMC Genomics 2008, 9:60 http://www.biomedcentral.com/1471-2164/9/60strong comparative induction in spleen and weakest
expression in the ileum. Macrophage receptor with colla-
genous structure (MARCO) mediates alveolar macro-
phages to bind, ingest and clear the inhaled particle and
bacteria [54]. MARCO only expressed on the marginal
zone macrophage of the spleen and macrophages of
meullary cord in lymph nodes in normal mice [55]. The
current study corroborates this as we also found MARCO
was highly expressed in spleen compared to other tissues.
To our knowledge, this is the first study to characterize tis-
sue expression in chickens using a whole genome array. A
total of four tissues were selected for this study. Two of
these (liver and spleen) are complete organs, which play
significant roles in many sophisticated biological func-
tions of the animals. The liver is responsible for lipid,
amino acid, and carbohydrate metabolism, while the
spleen is an essential part of immune function in animals.
The other two tissues (ileum and cecal tonsil) may have
less complicated functions than liver and spleen. The GO
analysis of global gene expression profiling among these
four tissues supported the notion that more clusters of
genes would be significantly enriched in the comparisons
of organ (liver and spleen) against tissues such as ileum
and cecal tonsil (Figures 4A, 4B, 5). The majority of func-
tional enrichments associated with gene regulation in the
liver comparisons were consistent with the roles of liver
[56]. In the spleen, there were many immune-related (cell
death, apoptosis, response to stimulus etc) clusters
enriched. In summary, the results above demonstrated
that this newly developed chicken 44K whole genome
array is a powerful genomic tool to investigate different
biological processes in chickens.
Conclusion
We have characterized a newly developed chicken 44K
whole genome oligonucleotide microarray using four
major tissues. This microarray in theory consists of probes
designed from the whole chicken transcriptome as well as
150 microRNAs, the entire genome sequences of Marek's
disease virus and two avian influenza virus genomes.
Comparison of gene expression among 2 organs and 2 tis-
sues has been submitted to GEO providing valuable com-
parative gene expression data to the scientific community.
Novel findings related to defensins and cathelicidin
expression in the spleen is highlighted. Additionally, the
custom tracks for sequences and probes used in this array
have been built for Chicken Genome Browser Gateway in
Table 4: Microarray and qRT-PCR results of 23 selected genes for each pair of comparison
Gene symbol Liver vs. cecal tonsil Liver vs. ileum Spleen vs. ileum
Microarray qRT-PCR Microarray qRT-PCR Microarray qRT-PCR
IGJ -2.6# -4.9 0.4 -2.6 5.3 # 4.5
VLDLR -1.5 # -1.4 -1.4 -0.7 1.8 # 2.8
LEAP-2 3.5 # 4.5 0.6 0.0 -3.8 # -10.1
Lb-FABP 7.8 # 12.7 7.6 # 11.7 -1.0 -0.9
TACSTD1 -3.8 # -0.3 -3.7 # -3.3 -5.7 # -6.8
CYP3A37 -0.5 0.0 -0.6 * 0.2 -3.7 # -14.6
C1QA 1.5 # 2.2 1.7 # 2.0 2.3 # 2.6
MARCO 2.1 # 2.2 2.2 # 3.5 2.8 # 6.0
BCMO1 2.6 # 3.0 0.6 * 1.0 -1.2 # -3.8
K60 -1.7 # -3.9 0.3 * -0.9 1.2 # 0.7
GSTA3 -0.2 3.0 2.0 # 4.0 -1.1 * -2.9
FIGF -3.6 # -2.4 -2.7 # -1.5 -1.6 # -0.9
CD5 -2.9 # -3.7 -0.2 -1.4 2.9 # 2.8
GAL10 4.9 # 10.6 4.9 # 9.5 -0.1 -3.2
TF 5.2 # 9.6 5.8 # 10.6 1.5 * 3.1
VIP -3.2 # -5.8 -3.8 # -6.4 -3.8 # -4.3
CXCL14 -2.5 # -11.1 -2.3 # -9.2 -2.3 # -5.9
HRSP12 2.9 # 3.6 3.2 # 3.4 -0.5 -2.6
C3 3.0 # 4.7 3.6 # 7.7 0.8 * 4.8
FABP1 7.8 3.6 7.6 0.9 -6.4 # -8.1
TNFSF10 -1.9 # -2.0 -1.4 # -1.8 -2.7 # -3.1
LCP2 -0.9 0.5 0.2 0.4 2.2 # 1.0
TIMD4 2.0 # 2.8 3.4 # 3.8 3.4 # 3.9
Note: All data are shown as log2, positive value means up regulated between tissue A vs. tissue B (tissue A – tissue B)
#represents P value for the comparison is less than 0.0001 in microarray results.
* represents P value for the comparison is between 0.05 and 0.0001 in microarray results.
Micrroarray results shown in bold font in diagonal are the results those were used to select genes for qRT-PCR for each comparison.Page 10 of 14
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BMC Genomics 2008, 9:60 http://www.biomedcentral.com/1471-2164/9/60UCSC providing an efficient tool to link genomic infor-
mation from this powerful genome browser to our expres-
sion data. This array will be a complimentary platform for
the scientific community to study genetics, immunology,
developmental biology, genomics, nutrition, and food
safety in chickens.
Methods
Tissue collection
Cecal tonsil (C), ileum (I), liver (L), and spleen (S) were
collected from six two-week commercial broilers. Total of
24 samples were immersed into 10 volumes of RNAlater
(Ambion, Austin, USA) and stored at -20°C until RNA
isolation.
Microarray design
Loop design and dye swap were used in the microarray
study (Figure 7). In brief, four different tissue samples
(cecal tonsil, ileum, liver, and spleen) from each chicken
were designed for one loop. The orders of the tissues in
different loops were changed so that there were four com-
parisons with a dye swap across all six pairs of tissue com-
parisons. Data from 12 measurements for each tissue were
collected, with total of 48 measurements from 24 arrays.
RNA isolation
Tissues were homogenized using a Tissue Miser (Fisher
Scientific, Houston, TX). Total RNA was isolated from
each homogenized tissue using Trizol extraction method
as described by the manufacturer (Invitrogen, Carlsbad,
CA). All of DNA was removed from the samples using
TURBO DNA free™ Kit (Ambion, Austin, TX) according to
the manufacturer's protocol. The RNA quantity and purity
were determined by NanoDrop ND-1000 spectropho-
tometer at 260/280 nm (Nano Drop Technologies, Wilm-
ington, Delaware). The integrity of total RNA was assessed
with an Agilent Bioanalyzer 2100 and RNA 6000 Nano
LabChip Kit (Agilent Technologies, Palo Alto, CA). The
RNA Integrity Numbers (RINs) for the samples were
obtained. Only RNA samples with RIN values of 6, or
higher, were used for the analysis.
cRNA preparation
A 500 ng of aliquot of total RNA was reverse transcribed
into cDNA using the Low RNA Input Fluorescent Linear
Amplification Kit (Agilent Technologies). The synthesized
cDNA was transcribed into cRNA and labelled with either
cyanine 3 or cyanine 5-labelled nucleotide (Perkin Elmer,
Wellesley, MA). Labelled cRNA was purified with RNeasy
Mini columns (Qiagen, Valecia, CA). The quality of each
cRNA sample was verified by total yield and specificity cal-
culated based on NanoDrop ND-1000 spectrophotome-
ter measurement (NanoDrop Technologies).
Microarray hybridization
Labelled cRNAs with specificity greater than 8 were used
for hybridization using the in situ hybridization kit plus
(Agilent Technologies). Arrays were incubated at 65°C for
17 h in Agilent's microarray hybridization chambers. After
hybridization, arrays were washed according to the Agi-
lent protocol.
Image processing
Arrays were scanned at 5-μm resolution using GenePix
Personal 4100A (Molecular Devices Corporation, Sunny-
vale, CA) and images were saved as TIFF format. Auto
Photomultiplier tube (PMT) settings were selected and
adjusted to get the ratio of the overall intensities between
two channels (Cy3 and Cy5) to 0.95 to 1.05. The signal
intensities of all spots on each image were quantified by
Genepix pro 6.0 software (Molecular Devices Corpora-
tion, Downingtown, PA), and data were saved as .txt files
for further analysis.
Normalization and statistical analysis
The signal intensity of each probe was divided by that of
negative control to filter the genes which were not
expressed. The signal intensity of each gene was globally
normalized using LOWESS within the R statistics package
[57]. A mixed model that included the fixed effects of dye
(Cy3 and Cy5), tissue, and random effect of slide and
array, was used to analyze the normalized data by SAS
(SAS Institute, Cary, NC). P value and fold changes
between each comparison for each gene were calculated.
One tissue was included in three comparisons, the signif-
icantly expressed genes among these three comparisons
were joined together to derive the selectively expressed tis-
The diagram of the microarray experiment designFigure 7
The diagram of the microarray experiment design. 
The arrow represents Cy3, the end of the arrow represents 
Cy5.
L iver 
S pleen 
Cecal tonsil 
Ileum 
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culated by R program according to Benjamini and
Hochberg's method [42].
Bioinformatics
An unreleased version of the High Throughput Gene
Ontology Functional Annotation Toolkit (HTGOFAT)
was utilized [58,59] to assign updated Gene Ontology
[60] numbers, Enzyme Commission [61] numbers, map-
pings to Kyoto Encylopedia of Genes and Genomes
(KEGG) Pathways [62] and updated definitions. Addi-
tionally, differentially regulated genes were mapped to
Protein Information Resource (PIR) keywords [63] and
COG [64] functional annotations through the use of the
Database for Annotation, Visualization and Integrated
Discovery (DAVID) [65]. Statistics related to over repre-
sentation of functional categories were performed using
DAVID, which is based upon a Fisher Exact statistic meth-
odology similar to that described by Al-Shahrour et al
[66]. A P < 0.001 was considered as significant.
Quantitative real-time PCR
Both up-regulated and down regulated genes from each
comparison were selected for quantitative real time PCR
(qRT-PCR). Four tissue samples from each chicken, and
total of sixteen samples from 4 chickens were used. All
reagents for qRT-PCR were loaded by Eppendorf ep
Motion 5070 workstation (Eppendorf, Westbury, NY). The
primers were designed with Primer 3 [67]. Gene symbols
and primers are listed in Table 2. A 1 ug aliquot of total
RNA was used to synthesize first-strand cDNA using ran-
dom hexamers and Thermoscript™ RT-PCR system (Invit-
rogen) in a reaction volume of 20 μL. The PCR reactions
were performed in a 10 ul volume containing a 1×SYBR
Green Master Mix, 50 ng cDNA, 300 nM of forward prim-
ers, 300 nM of reverse primers on an ABI Prism 7900HT
sequence detection system (Applied Biosystems, Foster
City, CA). The amplification condition was 50°C for 2
min; 95°C for 10 min, followed by 40 cycles of 95°C for
15 sec and 59°C for 1 min; a final soak at 4°C was also
incorporated. Glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) was used as the internal control. All of the
samples were measured in duplicate. Two measurements
of each tissue sample were averaged for further analysis.
The comparative Ct method was used to calculate the rel-
ative gene expression level across the tissues. Relative
expression level of each gene in one tissue (ΔCt) was cal-
culated by Ct target gene-Ct GAPDH; relative expression of each
gene in two different tissues (ΔΔCt) was calculated by ΔCt
A -ΔCt B.
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